These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 11782701

  • 1. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.
    Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
    [Abstract] [Full Text] [Related]

  • 2. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V, Mikhailidis DP, Barradas MA, Jeremy JY, Gracey L, Dandona P.
    Int J Clin Pharmacol Res; 1988 Dec; 8(5):377-81. PubMed ID: 3229875
    [Abstract] [Full Text] [Related]

  • 3. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL, Zheng Q, Worthy SA, Charles B, Bradley DV.
    Angiology; 2002 Dec; 53(5):509-20. PubMed ID: 12365857
    [Abstract] [Full Text] [Related]

  • 4. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
    Ciuffetti G, Sokola E, Lombardini R, Pasqualini L, Pirro M, Mannarino E.
    Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
    [Abstract] [Full Text] [Related]

  • 5. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 6. Buflomedil for intermittent claudication.
    De Backer TL, Vander Stichele RH, Bogaert MG.
    Cochrane Database Syst Rev; 2001 Feb 12; (1):CD000988. PubMed ID: 11279700
    [Abstract] [Full Text] [Related]

  • 7. [Platelet function after the single administration of buflomedil].
    Sinzinger H, Wirthumer-Hoche C.
    Wien Klin Wochenschr; 1985 Sep 27; 97(18):720-2. PubMed ID: 4072227
    [Abstract] [Full Text] [Related]

  • 8. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E, Bahnini A, Mouren X, Gamand S.
    Int Angiol; 2001 Mar 27; 20(1):58-65. PubMed ID: 11342997
    [Abstract] [Full Text] [Related]

  • 9. [Flunarizine in the treatment of arteriopathies of the legs].
    Catalano M, Sacchi E, Tomasini M, Coazzoli E, Parolini A, Dall'Oglio A, Libretti A.
    Ric Clin Lab; 1985 Mar 27; 15 Suppl 1():475-8. PubMed ID: 4035228
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication].
    Diehm C, Eckstein M, Hübsch-Müller C.
    Vasa; 1989 Mar 27; 18(1):40-7. PubMed ID: 2648691
    [Abstract] [Full Text] [Related]

  • 11. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT, Quinton DN, Barrie WW.
    N Z Med J; 1987 Jul 22; 100(828):445-7. PubMed ID: 3330188
    [Abstract] [Full Text] [Related]

  • 12. The effect of exogenous phosphocreatine on maximal walking distance, blood rheology, platelet aggregation, and fibrinolysis in patients with intermittent claudication.
    Panchenko E, Dobrovolsky A, Rogoza A, Sorokin E, Ageeva N, Markova L, Titaeva E, Anuchin V, Karpov Y, Saks V.
    Int Angiol; 1994 Mar 22; 13(1):59-64. PubMed ID: 8077800
    [Abstract] [Full Text] [Related]

  • 13. The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests.
    Koltai K, Feher G, Kesmarky G, Keszthelyi Z, Czopf L, Toth K.
    Clin Hemorheol Microcirc; 2006 Mar 22; 35(4):517-25. PubMed ID: 17148851
    [Abstract] [Full Text] [Related]

  • 14. A meta-analysis of randomized, double-blind, placebo-controlled studies of the effect of buflomedil on intermittent claudication.
    Walker GA, Mac Hannaford JC.
    Fundam Clin Pharmacol; 1995 Mar 22; 9(4):387-94. PubMed ID: 8566940
    [Abstract] [Full Text] [Related]

  • 15. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
    Van den Brande P, Maurel A.
    Angiology; 1998 Feb 22; 49(2):105-14. PubMed ID: 9482510
    [Abstract] [Full Text] [Related]

  • 16. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb 22; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 17. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G, Koltai K, Kesmarky G, Horvath B, Toth K, Komoly S, Szapary L.
    Phytomedicine; 2009 Mar 22; 16(2-3):111-7. PubMed ID: 19135345
    [Abstract] [Full Text] [Related]

  • 18. [Positive effect of intermittent overpressure and underpressure (Vacusac) in intermittent claudication].
    Mehlsen J, Himmelstrup H, Himmelstrup B, Winther Hansen KF.
    Ugeskr Laeger; 1994 Jan 10; 156(2):169-71. PubMed ID: 8296403
    [Abstract] [Full Text] [Related]

  • 19. A preliminary study on the effects of exercising to maximum walking distance on platelet and endothelial function in patients with intermittent claudication.
    Collins P, Ford I, Ball D, Macaulay E, Greaves M, Brittenden J.
    Eur J Vasc Endovasc Surg; 2006 Mar 10; 31(3):266-73. PubMed ID: 16360327
    [Abstract] [Full Text] [Related]

  • 20. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Mar 10; 53 Suppl 1():S7-12. PubMed ID: 11865838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.